Genetic Testing

A novel technique for robotic prostatectomy allowed men to regain continence early after prostate cancer surgery, according to a recent study. It was the top story in hematology/oncology last week.

The FDA approved the FoundationOne Liquid CDx test as a companion diagnostic device to help identify multiple additional biomarkers in cell-free DNA isolated from plasma, according to a press release from the agency.

The FDA approved the FoundationOne CDx test to help identify certain neurotrophic receptor tyrosine kinase gene fusions in patients with solid tumors eligible for treatment with larotrectinib, according to a press release from the agency.

The landmark TAILOR-PCI trial showed encouraging evidence for genotype-guided antiplatelet therapy.

All men with metastatic prostate cancer should undergo genetic testing to better inform decisions on precision medicine or clinical trial eligibility, according to recommendations developed at a multidisciplinary consensus conference.

Severe obesity starting early in life is a hallmark of rare genetic disorders of obesity. A genetic diagnosis can alleviate feelings of guilt or blame and lessen social stigma for youths with these disorders and their families.

In an Italian study of elite and amateur athletes with suspected inherited CVD, researchers demonstrated that the presence of more than three clinical markers was highly indicative of a positive diagnosis from genetic testing for CVD.

Among patients with non-small cell lung cancer who harbor MET exon 14 skipping mutations, or METex14+, savolitinib demonstrated tolerability and anti-tumor activity, according to findings from a phase 2 study presented at the virtual ASCO annual meeting.

Determine whether genetic testing identifies an antiplatelet therapy for patients undergoing PCI who do not tolerate clopidogrel well.

Adults with obesity and unfavorable lifestyle factors are more likely to develop type 2 diabetes during 15 years of follow-up than those without excess weight and favorable lifestyle factors, regardless of their genetic predisposition for the disease, according to findings published in Diabetologia.